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Abstract
Background: Patient experiences are an important aspect of health care quality, but there is a lack of validated
instruments for their measurement in the substance dependence literature. A new questionnaire to measure inpatients’
experiences of interdisciplinary treatment for substance dependence has been developed in Norway. The aim of this
study was to psychometrically test the new questionnaire, using data from a national survey in 2013.
Methods: The questionnaire was developed based on a literature review, qualitative interviews with patients, expert
group discussions and pretesting. Data were collected in a national survey covering all residential facilities with
inpatients in treatment for substance dependence in 2013. Data quality and psychometric properties were assessed,
including ceiling effects, item missing, exploratory factor analysis, and tests of internal consistency reliability, test-retest
reliability and construct validity.
Results: The sample included 978 inpatients present at 98 residential institutions. After correcting for excluded patients
(n = 175), the response rate was 91.4%. 28 out of 33 items had less than 20.5% of missing data or replies in the “not
applicable” category. All but one item met the ceiling effect criterion of less than 50.0% of the responses in the most
favorable category. Exploratory factor analysis resulted in three scales: “treatment and personnel”, “milieu” and
“outcome”. All scales showed satisfactory internal consistency reliability (Cronbach’s alpha ranged from 0.75-0.91) and
test-retest reliability (ICC ranged from 0.82-0.85). 17 of 18 significant associations between single variables and the
scales supported construct validity of the PEQ-ITSD.
Conclusion: The content validity of the PEQ-ITSD was secured by a literature review, consultations with an expert
group and qualitative interviews with patients. The PEQ-ITSD was used in a national survey in Norway in 2013 and
psychometric testing showed that the instrument had satisfactory internal consistency reliability and construct validity.
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Background
Patient-reported quality is an important component of
health care quality, and the routine collection of pa-
tients’ experiences as part of quality measurements in
health care has become widespread. Various populations
are asked to give their feedback about health care ser-
vices, providing patient-based information about the
functioning of specific health care services and the
health care system. Patient experiences have been linked
to patient safety and clinical effectiveness, giving a clear
clinical rationale for focus on such experiences [1].
Studies have shown that patient experiences are related
to patient satisfaction [2]. One issue with satisfaction sur-
veys is that they often report high satisfaction [3–6], chal-
lenging the usefulness of satisfaction surveys in quality
improvement work, and calling for a more nuanced and
multi-faceted approach [7]. Asking patients about their
experiences of the health care delivery system has been
identified as a useful method for establishing trends over
time and comparisons among providers [2].
Several countries have national programs for monitor-
ing and reporting on health care quality using patient
experience surveys [8]. These national efforts create a
need for standardized instruments of high quality, spe-
cialized for use in different settings [9]. Reliable and
valid data about users’ or patients’ experiences requires a
measurement tool developed and tested according to
rigorous and comprehensive methods. Such develop-
ment and testing of survey tools is challenging and a
task that requires the consideration of many psychomet-
ric questions, like what questionnaire development steps
are needed, establishing criteria for the psychometric
testing and cut-off values for the relevant statistical tests
[10]. The results from the development and the psycho-
metric testing of the measurement tool should be docu-
mented and appraised to ensure the tool’s properties.
Within the patient satisfaction field, a systematic review
revealed that such documentation and objective ap-
praisal are not always carried out, with less than half of
the included studies reporting some validity or reliability
data [11]. Such lack of evidence casts doubt on the cred-
ibility of the results derived from the use of these
instruments.
The Norwegian Institute of Public Health (NIPH) has
the responsibility for carrying out national patient ex-
perience surveys in Norway. Usually, the population of
interest is drawn at random from each service provider
and potential participants are invited by means of a
mailed questionnaire and invitation letter. The purpose
of the program is to systematically measure user experi-
ences of health care, as a basis for quality improvement,
health care management, patient choice and public ac-
countability. To serve this purpose, survey tools for dif-
ferent populations in health care have already been
developed and tested in Norway [12–22]. In 2013, the
Ministry of Health decided that a national patient ex-
perience survey of interdisciplinary treatment for sub-
stance dependence should be conducted. The
instrument bank in Norway lacked a validated question-
naire for this patient group, but a development and val-
idation project was already in progress and was
connected to the national survey that the Ministry had
decided on.
In the field of interdisciplinary treatment for substance
dependence, some validated questionnaires have been
identified in the international literature, one of which is
a quality-of-life instrument [23–28]. However, these are
used within differentiated treatments and among people
who use specific substances. Furthermore, several of
these are satisfaction measurements, and not targeted at
gathering information about patient experiences. Hence,
there is a paucity of surveys in substance dependence
treatment that can reliably and validly measure inpa-
tients’ experiences across treatments and types of sub-
stance use.
Within this field, research has shown that enhancing
patient satisfaction may improve treatment outcomes
[29–31]. A critical review within the field of addiction
treatment, by Trujols et al. published in [7], summarizes
important aspects of the evaluation of treatment. These
aspects include patients’ views on treatment, patients’
opinions about medication, relations with therapists and
influence on treatment, perception of needs and satisfac-
tion with treatment, as well as indicators of user-
perceived quality. However, these perspectives are not al-
ways in focus when evaluating the services [7].
The lack of a validated questionnaire for the measure-
ment of patient experiences with interdisciplinary treat-
ment for substance dependence led the Norwegian
Knowledge Centre for the Health Services (now NIPH)
to develop a new questionnaire for this patient group.
The development of the questionnaire followed the
standard methodology of our national program [12–22],
including a literature review, cognitive interviews with
patients and expert consultations. The questionnaire was
included in the national survey in 2013 that the Ministry
of Health decided on. The aim of this study was to test
the construct validity and internal consistency reliability
of a new questionnaire following the national survey in
Norway in 2013. The survey included all 98 residential




The Patient Experiences Questionnaire for Interdiscip-
linary Treatment for Substance Dependence (PEQ-
ITSD) was developed through a thorough process that
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included several recognized steps [12–22]. Firstly, a
comprehensive literature review was conducted to
search for valid and reliable questionnaires that could be
used in the Norwegian context. The review concluded
that there were no existing questionnaires ready and
relevant for large-scale use in a Norwegian setting [32].
Questionnaires, both from the review and Norwegian
questionnaires that had been used locally, were consid-
ered in terms of identifying important and relevant
topics for the new questionnaire. Secondly, an expert
group were consulted several times to discuss the con-
tent of the new questionnaire, as well as procedures for
data collection. The expert group consisted of seven per-
sons, including clinicians/therapists, researchers associ-
ated with treatment institutions and representatives
from interest groups. Thirdly, qualitative interviews were
conducted with 13 patients with various types of sub-
stance dependencies, with a focus on what they found to
be important while in treatment. Fourthly, the resulting
questionnaire was cognitively tested with patients (n =
15), and lastly, a pilot survey was conducted with 14 in-
stitutions (n = 329). The first version of the question-
naire included 45 questions [33].
Before the national survey, the questionnaire was ex-
panded with three modified items from the Patient
Enablement Instrument [34], and three questions about
help from the municipality [35]. The former was in-
cluded to obtain feedback from patients regarding out-
comes of treatment, using the same approach as a newly
published patient experience questionnaire for psychi-
atric inpatients [16]. The latter was included because of
the importance of continuity of care and primary health
care services in Norway for this patient group as well
[36]. The questionnaire included in the national survey
consisted of 51 closed-ended questions, most scored on
a scale from 1 “not at all” to 5 “to a very large extent”.
The topics covered in the questionnaire included “recep-
tion and waiting time”, “the therapists/the personnel”,
“the treatment”, “the milieu and activity provision”,
“preparations for the time after discharge”, “other assess-
ments” and “previous admissions in substance depend-
ence institutions”. The questionnaire also included
questions about the respondents’ background. In
addition to the closed-ended questions, there were two
open-ended questions. One asked the respondents to
write more about their experiences at the institution,
and the other asked the respondents to write about their
experiences of the help and care they had received from
their municipality.
Data collection
Data were collected through a national survey in 2013.
The survey was commissioned by the Norwegian Direct-
orate of Health and was mandatory for all relevant
institutions. The included institutions were all public
residential institutions and private residential institutions
with a contract with the regional health authorities. De-
toxification institutions were excluded. All patients aged
16 years and older were invited to fill out the
questionnaire.
The survey was developed as part of the national
program, but the very low rate of response to mailed
post-discharge surveys of psychiatric inpatients and
sub-groups of patients with substance dependence in
these surveys restricts their validity and usefulness
[37]. Consequently, this prompted a change to data
collection, from post-discharge to on-site. In contrast
to the NIPH’s standard data collection method, which
is to send a postal questionnaire a few weeks after
discharge to the patient’s home, all institutions carried
out the survey on-site by distributing questionnaires
to patients while in treatment. This data collection
approach is also used for psychiatric inpatients [16].
Questionnaires were sent to participating institutions,
where the institutions’ personnel were responsible for
distributing and collecting the questionnaires. Each pa-
tient received an envelope containing an information
sheet, the questionnaire and a reply envelope. Every
fourth envelope also contained a retest-questionnaire
and an additional reply envelope. The retest was to be
carried out approximately two days after the original
survey. The institutions were to ensure that the patients
completed the questionnaire by themselves, without dis-
cussing the questions or their answers with other pa-
tients, health personnel or staff. If needed, the patients
could receive help in reading and/or understanding the
questions, without being influenced on how to respond.
After the survey, the institutions reported to the NIPH
on the number of eligible patients, number of patients
who participated, number of patients who declined par-
ticipation and number of excluded patients. Based on
this information, the NIPH calculated adjusted gross
sample and response rates. No information about the
patients was gathered other than background questions
in the questionnaires, and hence the NIPH was able to
create an anonymous dataset based on the information
in the completed questionnaires.
Statistical analysis
Ceiling effect and item missing were assessed. Ceiling
effect is commonly understood as the percentage of
respondents answering in the most positive response
category. A large ceiling effect can indicate measure-
ment problems in respect of differentiating between
care providers or points in time. The cut-off for the
ceiling effect was set to 50%, i.e., an item was judged
as of adequate quality if the ceiling effect was smaller
than 50% [38, 39].
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Exploratory factor analyses were conducted to assess
the underlying dimensions of the questionnaire. Items
with more than 20% missing responses were excluded.
All other questions, except questions regarding back-
ground information and items about experiences with
other services than residential institutions, were entered
into exploratory factor analyses. As some correlation be-
tween the factors may be expected, principal axis factor-
ing and oblique rotation with Promax was applied. Two
separate factor analyses were conducted: The first factor
analysis was conducted with items concerning structure
and process. In the second analysis, all items related to
outcome (as reported at the time of the measurement)
were entered. Items with factor loading smaller than 0.4
were excluded, and the criterion for rotation was set to
eigenvalues greater than 1.
The internal consistency of the resulting scales was
assessed with the calculation of Cronbach’s α and item-
total correlation. Item-total correlation measures the
correlation of each item with the total score of the
remaining items of the scale. Cronbach’s α is an assess-
ment of the correlation between all items in the given
scale. The cut-off for the α was set to the commonly
used criterion of 0.7 or higher [40]. The criterion for
item-total correlation is less established, and 0.2 [10], 0.4
[15, 41–43] and 0.5 [44] have all been used.
Test-retest reliability was assessed through calculation
of the intraclass correlation coefficient (ICC). The ICC
was used to test the reliability of the scores by correlat-
ing test and retest scores for each scale. A correlation of
0.7 or greater was considered satisfactory.
Construct validity relates to the degree to which the
measurement actually measures a specific underlying
construct [10]. This can be tested through assessing
the association of the measurement’s scales with other
variables known to influence the construct of interest.
A systematic review found that some variables were
relevant across populations: age and health status [2].
Based on a literature search, previous work and ex-
perts’ advice, it was hypothesized that the scale scores
would correlate with type of misuse [26, 45], more
specifically that patients with alcohol dependence
would report better experiences. Shorter waiting time
before treatment [24, 46] and less extent of forced
treatment [16] were also hypothesized to influence
the scale scores positively. Age [2, 26, 45, 47–49] was
expected to positively correlate with scale scores. Fur-
thermore, it was hypothesized that patients reporting
better self-perceived physical and psychological health
would report better experiences [2, 45]. Independent
samples t-test was conducted for type of misuse,
while Pearson’s r was used to assess correlations for
all other variables.
All analyses were conducted using SPSS version 23.0.
Results
On the day of the survey, the 98 participating institu-
tions had a total of 1245 admitted patients. 12 patients
were excluded due to ethical considerations and 163
were not present at the institution when the survey was
conducted. Hence, the corrected sample was 1070 eli-
gible patients. 978 patients filled out and returned the
questionnaire, resulting in a response rate of 91.4%.
Two thirds of the sample were male with a mean age
of 36.5 years (Table 1). 80.3% were single, and 11.9% had
university or college education. The respondents’ mean
age when they developed a substance dependence was
20.3 years. 62.4% and 54.6% reported their physical and
mental health as excellent, very good or good, respect-
ively. 32.5% had no previous admissions to residential
treatment, and 53.7% had been at the institution less
than 3 months. The most frequently used substances
prior to admission were cocaine/amphetamine (47.1%)
and alcohol (46.4%). 58.9% reported two or more sub-
stances as the most frequently used substance.
The levels of missing data ranged from 1.9% to 4.9%
(Table 2), while the responses in the “not applicable” cat-
egory ranged from 0.3% to 29.6%. Five out of the 33
items had more than 20.4% item-missing (missing data
+ not applicable). The five items were #12c: benefit of
treatment with medication; #18: help for psychological
distress; #27 and #28: help with practical issues and fur-
ther treatment after discharge; and #34: the personnel’s
cooperation with patients’ next of kin.
All items, with one exception, met the criterion of less
than 50.0% responses in the most favorable category.
The exception was item #36 regarding malpractice,
where 51.4% of the respondents answered “not at all”.
A total of 27 items were included in the two factor
analyses. Twenty items addressing structure and process
were entered in the first factor analysis. Three items
were excluded from the analysis, one at a time, due to
low factor loadings. Hence, 17 items were entered in the
final analysis, resulting in two factors that explained
51.8% of the variance (Table 3). Initially, seven items
concerning outcomes were entered in the second factor
analysis. Two items were removed due to the wording of
the questions, asking for assessments of specific treat-
ment initiatives. Hence, five general outcome items were
entered in the second factor analysis, resulting in one
factor which explained 73.4% of the variance. Cronbach’s
α for the three scales ranged from 0.75 (factor 2 – “mi-
lieu”) to 0.91 (factor 1 – “treatment and personnel” and
factor 3 – “outcome”), all of which were above the 0.7
criterion. The scales showed good test-retest reliability;
all factors had a reliability greater than 0.8.
The associations between the scale scores and the
tested variables were statistically significant in 17 out of
18 tests (Table 4). Independent Samples T-Test showed
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that patients reporting alcohol as their single used sub-
stance before treatment entry scored significantly higher
on all three scales compared to patients who reported
other types of substance dependencies. When comparing
age and reported type of substance dependence, we
found that those reporting only alcohol as their type of
misuse are generally older (mean age 50 for alcohol,
mean age 33 for other). Further testing showed that, for
“treatment and personnel” and “outcome”, the effect of
age disappears when controlling for alcohol use. How-
ever, since the effect of age was statistically significant
for “milieu” when controlling for alcohol, both variables
were kept in the model for construct validity testing.
Discussion
The data for this study was collected as part of the na-
tional patient experience program in Norway. It was the
first national survey of patient experiences of interdiscip-
linary treatment for substance dependence. The PEQ-
ITSD was designed for use among inpatients, and fo-
cuses on topics patients have reported to be important.
The questionnaire was developed after a thorough re-
view of the literature, meetings in an expert group, inter-
views with patients and results from a pilot survey. The
testing and evaluation of the PEQ-ITSD showed that the
questionnaire comprised three scales with excellent in-
ternal consistency reliability, test-retest reliability and
construct validity. Furthermore, the questionnaire
showed good acceptability given the high response rate
and low proportion of item missing.
The questionnaire comprises three scales, resulting
from two factor analyses. These three scales correspond
to the scales found in the on-site survey of psychiatric
inpatients in Norway, a survey conducted by the same
methods as the current study [16]. It is somewhat diffi-
cult to compare the PEQ-ITSD with other instruments
of interest, given the variation in the populations sur-
veyed and the aim of the instruments. However, some
parallels are found between the PEQ-ITSD’s three scales
and other instruments used in similar populations. The
scales resemble to some extent both the Treatment Out-
come Profile (TOP) [23] and the Treatment Perceptions
Questionnaire (TPQ) [24], emphasizing the importance
to the patients of the areas and topics constituting the
PEQ-ITSD. The user satisfaction scale of TOP consists
of three subscales; satisfaction with treatment; satisfac-
tion with staff; satisfaction with environment, each con-
sisting of three items. The two scales constituting the
TPQ focus on perceptions of staff and treatment pro-
gram. However, the TOP was primarily developed for
use among patients in psychiatric care, and only second-
arily tested for use among patients in treatment for sub-
stance dependence, while the testing of levels of validity
and reliability was insufficient for both instruments.










Primary school 383 41.3
Secondary school 434 46.8
University or college 110 11.9





Very good 192 20.6
Good 330 35.4




Very good 145 15.6
Good 317 34.0
Quite good 260 27.9
Poor 163 17.5







Length of stay at this institution
0-2 weeks 144 14.8
3-11 weeks 377 38.9
3-6 months 257 26.5
7-12 months 147 15.2
More than 12 months 45 4.6
Previous admissions
No 304 32.5
Yes, once 243 26.0
Yes, twice 167 17.9
Yes, 3-5 times 136 14.6
Yes, more than 5 times 84 9.0
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Table 2 Item descriptives
n Missing (%) Not applicable (%) Meana Ceiling (%)
3 Were you informed of the institution’s rules and routines
when you arrived?
950 2.9 - 3.59 17.5
4 Were you welcomed in a satisfactorily manner when admitted
to the institution?
950 2.9 - 3.98 30.5
6 Have you had enough time for talk and contact with
clinicians/personnel?
947 2.4 0.8 3.51 18.4
7 Do you perceive that the clinicians/personnel have understood
your situation?
950 2.5 0.4 3.65 19.9
8 Have you had confidence in the clinicians’/personnel’s professional
competence?
943 2.7 0.9 3.68 23.2
9 Has one of the clinicians/personnel had primary responsibility
for you?
927 3.3 1.9 3.75 28.7
10 To what extent have you been met with courtesy and respect? 945 3.1 0.3 4.16 39.4
12a What benefit have you had from treatment in groups
at the institution?b
861 3.3 8.7 3.33 15.8
12b What benefit have you had from talking to a therapist
at the institution?b
910 3.0 4.0 3.56 21.5
12c What benefit have you had from treatment by medication
at the institution?b
641 4.9 29.6 3.16 17.0
13 All in all, what benefit have you gained from the treatment
at the institution?b
913 4.2 2.5 3.85 30.8
14 Has the information you have received regarding the treatment
been satisfactory?
930 3.1 1.8 3.44 13.8
15 Have you had influence on your treatment? 926 3.1 2.2 3.53 17.0
16 Do you perceive that the treatment has been adjusted
to your needs?
934 2.9 1.6 3.46 16.0
17 Have you received help for physical ailments or illness? 782 3.1 17.0 3.20 12.5
18 Have you received help for psychological distress? 763 3.8 18.2 3.09 12.8
19 Has your access to psychologists been satisfactory? 843 2.7 11.1 3.13 15.8
20 Has your access to medical doctors been satisfactory? 918 2.8 3.4 3.33 15.5
21 Have you felt safe at the institution? 959 1.9 - 4.17 38.5
22 Has the institution arranged for contact with other patients
in a satisfactory manner?
955 2.4 - 3.78 23.6
23 Have the activities offered at the institution been satisfactory? 958 2.0 - 3.42 16.9
24 Have the meals at the institution been satisfactory? 958 2.0 - 3.92 38.0
25 Have you been satisfied with the possibility for privacy? 950 2.9 - 3.43 19.7
26 Do you perceive that the clinicians/personnel have prepared
you for the time after discharge?
816 2.8 13.8 2.97 8.8
27 Do you perceive that the clinicians/personnel have helped
you with practical issues for the time after discharge
(e.g. housing, finances, work/school)?
727 3.0 22.7 2.81 9.4
28 Do you perceive that the clinicians/personnel have arranged
for further treatment for the time after discharge?
748 3.3 20.2 2.89 9.6
29 Do you perceive that the clinicians/personnel have helped you
so you can achieve a meaningful life after discharge?
784 3.1 16.8 3.12 13.0
30 All in all, is the help and treatment you receive at the institution
satisfactory?
929 2.0 3.0 3.76 23.8
31 Do the help and treatment you receive at the institution improve
your ability to understand your dependency problem?
927 2.0 3.2 3.64 23.6
32 Do the help and treatment you receive at the institution improve
your ability to cope with your dependency problem?
902 2.0 5.7 3.61 20.7
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Accordingly, and given that the population in question
consisted of all patients undergoing treatment for differ-
ent types of misuse, it was necessary to develop a new
questionnaire for use with a heterogeneous population
in residential treatment for substance dependence.
The rationale for conducting two analyses was to avoid
contamination between the outcome items and those
concerning structure and process. The three scales may
enable the institutions to identify areas where the qual-
ity, as seen by the patients, should be improved. The
scales, along with feasible case mix adjustments, contrib-
ute to more valid comparisons across both institutions
and time.
Through the search for relevant literature, it was dis-
covered that there were a general lack of literature ad-
dressing issues of psychometric properties in
questionnaires used in surveys of patients in substance
dependence treatment. This is also supported by an
overview of user satisfaction surveys in addiction ser-
vices [7]. Furthermore, there is a general lack of vali-
dated patient experience instruments within this field [7,
32]. Due to the insufficient literature, the hypotheses for
the construct validity testing were based on what was
identified through the literature review of patient experi-
ences of treatment for substance dependence, on the
general literature on patient experiences, and on advice
from experts from whom advice was sought. Six inde-
pendent variables were suggested. Since little is known
about what variables are most important in the given
population, all six variables were entered in the validity
testing for a more exploratory approach.
Most hypothesized associations were statistically sig-
nificant. Several studies have found that age is associated
with satisfaction or experiences [2, 26, 45, 47–49]. The
patients’ age was associated with the “treatment and
personnel” and “milieu” scales. However, it was not sig-
nificantly associated with “outcome”. The age effect is
mostly evident through older patients being less critical
than younger patients. In the current data, the patients
are, on average, younger than other populations, e.g.
somatic inpatients. The mean age in the population re-
plying to the PEQ-ITSD was 36.5 years. As previously
described, both alcohol use and age were associated with
the scale scores. However, testing showed that patients
reporting only alcohol as their dependence are older
than patients reporting other types of dependencies, and
that the effect of age disappears when controlling for al-
cohol use for two of the three scales. All significant cor-
relations showed associations according to the
hypotheses.
The patient experience surveys conducted by the
NIPH are usually carried out as postal surveys. Patients
are sent a postal invitation to answer a questionnaire
after their hospital visit or doctor’s appointment. How-
ever, due to expert advice and previous experience with
low response rates among patients within psychiatric
care, an on-site data collection method was chosen for
the population at hand. In addition, previous research
has concluded that personal contact in recruitment and
data collection may increase the response rate [50, 51].
There are some concerns regarding the possible differ-
ences in responses that are elicited from postal surveys
versus on-site data collection. Even though on-site data
collection might increase the response rate and therefore
increase the representativeness of the data, on-site data
collection often results in more favourable responses
compared to mailed surveys [52–54].
When deciding to collect the data on site, there are
at least two possibilities: at discharge or as a cross-
sectional study. One strength of the design that asks
for participation at discharge is that the patients have
been through their entire treatment, and therefore
may be better able to answer all questions. In
addition, the patients who have completed their treat-
ment may have other experiences than those who
have been in treatment for a shorter amount of time.
A limitation of the same design is that the patients
who drop out of treatment will not be reached. Fur-
thermore, for institutions where patients are supposed
to stay for a longer period of time, the inclusion
period for obtaining a large enough sample can be
very long, adding to the challenges of anonymity and
outdated data. In the work on developing the ques-
tionnaire, both approaches were tested. It was found
that the two approaches elicited somewhat different
evaluations of the treatment and the institutions, but
that a cross-sectional study was well suited to includ-
ing all patients, and minimizing the work load on the
Table 2 Item descriptives (Continued)
33 Do the help and treatment you receive at the institution give you
faith that your life will improve after discharge?
914 2.2 4.3 3.74 26.0
34 Do you perceive that the clinicians/personnel have cooperated
well with your next-of-kin?
714 2.1 24.8 2.71 9.4
36 Do you believe that you have been subjected to malpractice
(based on your own opinion)?c
910 2.4 4.6 1.84 51.4
a All items were scored on a 5-point response scale ranging from 1 (“not at all”) to 5 (“to a very large extent”)
b Items with 5-point response scale ranging from 1 (“no benefit”) to 5 (“very large benefit”)
c Items with reversed response scale, i.e. the lower the mean, the better the result
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employees, while tolerating the somewhat worse eval-
uations [33].
The PEQ-ITSD’s three scales will be further tested
for feasibility for use as external quality indicators.
However, even though the scales have good psycho-
metric properties and present a more robust result
than single items, some important items were ex-
cluded after the psychometric testing. The items in the
questionnaire have all been reported as important to
the patients, and the questionnaire should therefore
not be reduced to merely the items comprising the
three scales.
The psychometric testing of the PEQ-ITSD has shown
that the data collected are of satisfactory quality, and
that the questionnaire shows excellent psychometric
properties. The instrument has been developed and
tested for a population seldom previously invited to par-
ticipate in similar surveys.









Treatment and personnel 0.91 0.85
26 Do you perceive that the clinicians/personnel have prepared you
for the time after discharge?
0.83 0.68
29 Do you perceive that the clinicians/personnel have helped you
so you can achieve a meaningful life after discharge?
0.76 0.68
6 Have you had enough time for talk and contact with clinicians/
personnel?
0.73 0.70
17 Have you received help for physical ailments or illness? 0.64 0.56
16 Do you perceive that the treatment has been adjusted to your
needs?
0.64 0.72
14 Has the information you have received regarding the treatment
been satisfactory?
0.62 0.74
7 Do you perceive that the clinicians/personnel have understood
your situation?
0.59 0.73
15 Have you had influence on your treatment? 0.59 0.61
19 Has your access to psychologists been satisfactory? 0.56 0.53
20 Has your access to medical doctors been satisfactory? 0.54 0.55
9 Has one of the clinicians/personnel had primary responsibility
for you?
0.52 0.51




21 Have you felt safe at the institution? 0.79 0.60
4 Were you welcomed in a satisfactorily manner when admitted
to the institution?
0.69 0.57
10 To what extent have you been met with courtesy and respect? 0.63 0.59
22 Has the institution arranged for contact with other patients
in a satisfactory manner?
0.54 0.51
24 Have the meals at the institution been satisfactory? 0.48 0.39
Outcomea 0.91 0.82
32 Do the help and treatment you receive at the institution
improve your ability to cope with your dependency problem?
0.87 0.82
30 All in all, is the help and treatment you receive at the
institution satisfactory?
0.83 0.78
33 Do the help and treatment you receive at the institution
give you faith that your life will improve after discharge?
0.81 0.76
31 Do the help and treatment you receive at the institution
improve your ability to understand your dependency problem?
0.81 0.76
13 All in all, what benefit have you gained from the treatment
at the institution?
0.77 0.73
aSeparate factor analysis for “Outcome”
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Limitations
While the PEQ-ITSD has been developed and tested
through rigorous methods as part of the national pro-
gram in Norway, there are some limitations to both the
questionnaire and this study. Every residential treatment
facility, both public and private, was included. This
means that the included institutions vary considerably
regarding e.g. size of the patient population, type of sub-
stance dependence, and method of treatment. Many of
the participating institutions are quite small and thus
have few responders.
Another limitation of the design is that the data are
collected anonymously. That is, no information about
the respondents is gathered, other than what the respon-
dents themselves report in the questionnaires. This de-
sign means that there is no available information about
those who chose not to participate in the survey, and
hence no knowledge of whether the respondents differ
from the non-respondents in any systematic way. In
other words, it is unknown whether the data are influ-
enced by non-response bias, which may pose a threat to
the generalizability of the results. However, the national
survey of 2013 had a response rate of 91.4%, leading to
the conclusion that non-response bias constitutes a
minor issue in this population.
The described questionnaire has been developed and
tested for use with inpatients on-site, and the
generalizability to other populations, such as detoxifica-
tion patients, out-patient clinics or discharged patients,
is unknown.
Conclusions
The PEQ-ITSD has shown excellent measurement prop-
erties, such as internal consistency reliability, test-retest
reliability and construct validity. The questionnaire com-
prises important themes elicited from patients and ex-
perts. The PEQ-ITSD can be used to measure inpatients’
experiences of interdisciplinary treatment for substance
dependence; however more research and testing are
needed to assess its feasibility for use in producing qual-
ity indicators.
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